PUBLISHER: DelveInsight | PRODUCT CODE: 1337659
PUBLISHER: DelveInsight | PRODUCT CODE: 1337659
Cardiovascular Imaging Equipment Market By Type Of Devices (Echocardiography, Angiography, Nuclear Cardiac Imaging, Computed Tomography, Cardiac Positron Emission Tomography (Cardiac Pet), and Cardiac Magnetic Resonance Imaging (Cardiac MRI)), End-User (Hospitals, Specialty Clinics, Diagnostic Imaging, and Others), and Geography is expected to grow at a Steady CAGR Forecast till 2028 owing to rising burden of cardiovascular diseases and introduction of technologically advanced systems
The global cardiovascular imaging equipment market was forecasted during the period from 2023 to 2028. The demand for cardiovascular imaging equipment is primarily motivated by the rising burden of cardiovascular diseases, the increasing number of risk factors associated with cardiovascular diseases, the introduction of technologically advanced systems, and others during the forecast period.
The major factor accelerating the growth of cardiovascular imaging equipment is the growing prevalence of cardiovascular diseases across the globe. According to the American Heart Association 2022, about 244.1 million people were globally living with coronary (ischemic) heart disease in 2020.
As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.
The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the most commonest and prevalent cardiovascular conditions worldwide in 2019.
According to Pan American Health Organization (PAHO) 2022, cardiovascular diseases cause more deaths yearly than any other disease. Heart disease and stroke-related fatalities account for more than three-quarters of all deaths in low- and middle-income nations in 2021.
Cardiovascular imaging equipments are essential for the effective diagnosis of cardiovascular diseases.
Further, in June 2020, Canon Medical Systems USA, Inc. introduced a new configuration of the Aquilion ONE/GENESIS Edition - the Aquilion ONE / GENESIS SP - a complete CT solution with proven cardiovascular capabilities. Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs. Such initiatives from companies and regulatory authorities are expected to help the patients in their treatment which will drive the cardiovascular imaging equipment market growth.
However, certain factors such as a lack of skilled professionals and risks such as exposure to harmful radiation, and others associated with cardiovascular imaging equipment may pose a minor hurdle to the growth of the cardiovascular imaging equipment market.
Cardiovascular Imaging Equipment Market By Type of Devices (Echocardiography, Angiography, Nuclear Cardiac Imaging, Computed Tomography, Cardiac Positron Emission Tomography (Cardiac PET), and Cardiac Magnetic Resonance Imaging (Cardiac MRI)), End-User (Hospitals, Specialty Clinics, Diagnostic Imaging, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the types of devices segment of cardiovascular imaging equipment, the Echocardiography category is expected to have a significant market share during the forecast period.
Echocardiography remains the primary tool in the diagnosis and monitoring of heart diseases due to its advantages and applications. It is a test that uses sound waves to produce live images of the heart, called an echocardiogram. This test allows the doctor to monitor how the heart and its valves are functioning.
In addition, it is relatively cheaper, quicker, and has fewer adverse effects. Currently, the fusion of different imaging modalities is gaining popularity for cardiovascular interventions, as it helps generate high-quality images that facilitate real-time monitoring in the operation theatre.
The concept of handheld ultrasound is growing popular in the echocardiography market. Echocardiography is emerging as a substantial competitive threat to diagnostic nuclear cardiology.
With technological advancements, and increasing investments towards developing new echocardiography devices, the cardiovascular imaging equipment market is expected to witness a boost.
It is expected to further grow on the back of real-time monitoring features.
Hence, all the above-mentioned factors are expected to revive the segment growth in the cardiovascular imaging equipment market.
North America is expected to dominate the overall Cardiovascular Imaging Equipment market during the forecast period. This domination is due to the growing number of individuals with cardiac diseases, changing lifestyles, rising geriatric population, presence of key players, increasing product development activities in the region, and others during the forecast period.
The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.
Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.
The increasing number of product development activities in the region is further going to accelerate the growth of the cardiovascular imaging equipment market.
Some of the key market players operating in the cardiovascular imaging equipment market include Toshiba, GE Healthcare, Siemens Healthcare, Philips Healthcare, Epsilon Imaging, and others.